InsidersTradesSigma
GeoVax Labs, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:geovax-labs-inc-cd3935US·SEC (Form 4)Mcap 8M€Healthcare
Explore the full management transaction log of GeoVax Labs, Inc., a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, GeoVax Labs, Inc. has recorded 4 insider filings. Market capitalisation: €7.7m. The latest transaction was reported on 28 June 2022 — Acquisition. Among the most active insiders: McKee Kelly T. Jr.. The full history is accessible without an account.
4
Insider Decl.
0
Thresholds
€26,196
4 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.21 €
Analyst consensus
3 analystsStrong buy
10.00 €Target 77.50 €(+3415%)212.50 €
Income statement
Revenue2.5 M€
Net income−21.5 M€-862.3% margin
Valuation
P/Book12.6x
Balance sheet & cash
Market cap7.7 M€
Total debt843 k€
Free Cash Flow−21.5 M€
Debt / Equity80%
Profitability & ownership
ROE-509.3%
ROA-194.6%
% insiders0.1%
% institutions9.8%
Last declaration on 28 June 2022
Declarations4 total
Executives▲Purchase◆Signal · 60SEC
€4,7254,464 shares@ €1.05850.062% mcap32.1% of flow
Common Stock
SEC:0001437749-22-016072:0·
Ideal exit: 24 Mar 2023 (T+270)
Executives▲Purchase◆Signal · 49SEC
€11,48810,000 shares@ €1.14880.15% mcap100.0% of flow
Common Stock
SEC:0001437749-22-015552:0·
Ideal exit: 18 Mar 2023 (T+270)
Executives▲Purchase32SEC
€6,6419,722 shares@ €0.68310.087% mcap45.2% of flow
Common Stock
SEC:0001437749-22-011257:0·
Ideal exit: 30 Jan 2023 (T+270)
Executives▲Purchase26SEC
€3,3414,999 shares@ €0.66840.044% mcap22.7% of flow
Common Stock
SEC:0001437749-22-011137:0·
Ideal exit: 29 Jan 2023 (T+270)
4 of 4 declarations